InvestorNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Participation in Microcap Rodeo Winter Wonderland Conference
Feb 16, 2021
AzurRx BioPharma (NASDAQ: AZRX), a company specializing in the development of nonsystemic, recombinant therapies for gastrointestinal diseases, has announced that it will present at the upcoming Microcap Rodeo Winter Wonderland Conference. The virtual conference is slated for Feb. 16–19, 2021. AzurRx CEO James Sapirstein is scheduled to make a live company presentation during the conference. The AzurRx presentation is scheduled for 4:30 p.m. ET on Feb. 17. During the presentation, Sapirstein will provide an overview of AzurRx’s business and clinical development programs; he will also talk about milestones anticipated throughout the coming year. Following the presentation, Sapirstein and other AzurRx executives will be available to meet one-on-one with registered investors.
To register for the event, visit https://ibn.fm/AtvyK
To view the full press release, visit https://ibn.fm/TiWOg
About AzurRx BioPharma Inc.
AzurRx BioPharma is a clinical-stage biopharmaceutical company specializing in the development of targeted, nonsystemic therapies for gastrointestinal (“GI”) diseases. The company has a pipeline of three gut-restricted GI assets. The first is MS1819, a recombinant lipase biologic for the treatment of exocrine pancreatic insufficiency (“EPI”) in patients with cystic fibrosis and chronic pancreatitis, with two ongoing phase 2 clinical trials. The other two are clinical-stage therapies using proprietary formulations of niclosamide, a pro-inflammatory pathway inhibitor: FW-420, for the treatment of grade 1 immune checkpoint inhibitor associated colitis (“ICI-AC”) and diarrhea in oncology patients, and FW-1022, for the treatment of COVID-19 gastrointestinal infections. The company is headquartered in Delray Beach, Florida, with clinical operations in Hayward, California. For more information, visit the company’s website at www.AzurRx.com.
NOTE TO INVESTORS: The latest news and updates relating to AZRX are available in the company’s newsroom at https://ibn.fm/AZRX
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.
More News
What Do You Want to Know About New York Times Journalism and A.I.?
New York Times journalists want to answer your questions about how we’re using artificial intelligence in our report.
Jensen Huang’s Affairs That Upended Nvidia: Timeline of Events
News of the Nvidia co-founder’s relationship with a suspected Chinese spy, and his affair with an executive who reports to him, prompted his exit from the multi-trillion-dollar company.
Jensen Huang Joins a Growing Club: C.E.O.s Brought Down by Affairs
The Nvidia founder and chief executive, who resigned on Thursday, is among a group of top bosses whose personal relationships and sexual encounters got them in trouble.
Some under-25s should get fewer benefits, Milburn review to say
The proposed radical overhaul of the welfare system would move under-25s off the main sickness benefits.
Jensen Huang’s Resignation From Nvidia Could Complicate Billions in Philanthropic Giving
Mr. Huang, the company’s co-founder, and his wife oversee a charitable foundation with about $9 billion in assets.
The rise and fall of Jensen Huang - how the tech superstar became mired in scandal
Within days, Huang's status as a seemingly untouchable figure leading the global tech race has crumbled.
Hospitals Brace for Medicaid Work Rules and Deep Funding Cuts
Health systems are racing to guide millions of patients through new eligibility hoops, slated to go into effect Jan. 1.
What we know as Nvidia CEO Jensen Huang resigns over affair allegations
The billionaire tech executive has left the company following reports of a second extramarital affair.
Who is Nvidia's interim CEO Colette Kress - and who could take over permanently?
Chief financial officer Colette Kress in in charge of Nvidia for now, but several others are in the frame as potential successors.
Data Centers Will Continue to Be Built, Despite Midterm Elections
Big technology companies saw the tide turn against their giant A.I. projects, but they have the means to weather delays.
Help! A Broken Toilet Grounded My Plane, and the Airline Won’t Cover a Hotel.
Turkish Airlines tried to wiggle out of paying for a passenger’s $512 overnight stay after a stomach-churning malfunction forced it to cancel a flight in Denver.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.